These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2849968)

  • 1. Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action.
    Caldwell JE; Castagnoli KP; Canfell PC; Fahey MR; Lynam DP; Fisher DM; Miller RD
    Br J Anaesth; 1988 Dec; 61(6):693-7. PubMed ID: 2849968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.
    Caldwell JE; Canfell PC; Castagnoli KP; Lynam DP; Fahey MR; Fisher DM; Miller RD
    Anesthesiology; 1989 Jan; 70(1):7-12. PubMed ID: 2536254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative potency of pipecuronium bromide and pancuronium bromide.
    Stanley JC; Mirakhur RK
    Br J Anaesth; 1989 Dec; 63(6):754-5. PubMed ID: 2558699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and cardiovascular dynamics of pipecuronium bromide during coronary artery surgery.
    Wierda JM; Karliczek GF; Vandenbrom RH; Pinto I; Kersten-Kleef UW; Meijer DK; Agoston S
    Can J Anaesth; 1990 Mar; 37(2):183-91. PubMed ID: 2155718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and disposition of pipecuronium bromide in dogs with and without ligated renal pedicles.
    Khuenl-Brady KS; Sharma M; Chung K; Miller RD; Agoston S; Caldwell JE
    Anesthesiology; 1989 Dec; 71(6):919-22. PubMed ID: 2556065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and disposition of pipecuronium bromide in the cat.
    Agoston S; Vandenbrom RH; Wierda JM; Houwertjes MC; Kersten UW
    Eur J Anaesthesiol; 1988 Jul; 5(4):233-42. PubMed ID: 2848702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics, urinary and biliary excretion of pipecuronium bromide.
    Wierda JM; Szenohradszky J; De Wit AP; Zentai G; Agoston S; Kakas M; Kleef UW; Meijer DK
    Eur J Anaesthesiol; 1991 Nov; 8(6):451-7. PubMed ID: 1662599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of succinylcholine on the pharmacodynamics of pipecuronium and pancuronium.
    Dubois MY; Fleming NW; Lea DE
    Anesth Analg; 1991 Mar; 72(3):364-8. PubMed ID: 1847278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and metabolism of pipecuronium bromide (Arduan)].
    Vereczkey L
    Acta Pharm Hung; 1992 May; 62(3):127-31. PubMed ID: 1323914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of pipecuronium bromide (Arduan) in elderly surgical patients.
    Ornstein E; Matteo RS; Schwartz AE; Jamdar SC; Diaz J
    Anesth Analg; 1992 Jun; 74(6):841-4. PubMed ID: 1317685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pipecuronium and pancuronium on the isolated rabbit heart.
    Deam RK; Soni N
    Br J Anaesth; 1989 Mar; 62(3):287-9. PubMed ID: 2564784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection.
    Furuta T; Canfell PC; Castagnoli KP; Sharma ML; Miller RD
    J Chromatogr; 1988 May; 427(1):41-53. PubMed ID: 2900840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Naguib M; Abdulatif M
    Can J Anaesth; 1991 Sep; 38(6):722-7. PubMed ID: 1655299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.